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of Pharmacy, Dongguk University, Goyang, KoreaABSTRACT Lactophoricin (LPcin-I) is an antimicrobial, amphiphatic, cationic peptide with 23-amino acid residues isolated
from bovine milk. Its analogous peptide, LPcin-II, lacks six N-terminal amino acids compared to LPcin-I. Interestingly, LPcin-II
does not display any antimicrobial activity, whereas LPcin-I inhibits the growth of both Gram-negative and Gram-positive
bacteria without exhibiting any hemolytic activity. Uniformly 15N-labeled LPcin peptides were prepared by the recombinant
expression of fusion proteins in Escherichia coli, and their properties were characterized by electrospray ionization mass spec-
trometry, circular dichroism spectroscopy, and antimicrobial activity tests. To understand the structure-activity relationship of
these two peptides, they were studied in model membrane environments by a combination of solution and solid-state NMR spec-
troscopy. We determined the tertiary structure of LPcin-I and LPcin-II in the presence of dodecylphosphorylcholine micelles by
solution NMR spectroscopy. Magnetically aligned unflipped bicelle samples were used to investigate the structure and topology
of LPcin-I and LPcin-II by solid-state NMR spectroscopy.INTRODUCTIONAntimicrobial peptides are essential for the innate immune
system of all life forms. Their broad spectrum antimicrobial
activities make antimicrobial peptides potentially useful for
pharmacological applications and commercial exploitation
(1–3). These peptides are believed to kill the target cells
by disrupting the ordered structures of cell membranes via
barrel-stave, carpet, or toroidal mechanisms (4). Under-
standing the structure-activity relationship of these peptides
is essential for developing them into novel therapeutics
that can substitute for traditional antibiotics. Unfortunately,
these membrane-targeting peptides are resistant to the
growth of crystals in membranes or detergents, rendering
x-ray diffraction inapplicable. The membrane-bound struc-
tures of antimicrobial peptides are primarily elucidated in
membrane-mimetic models, such as organic solvents and
lipid micelles, by solution NMR techniques (5). Organic
solvents are very convenient to manipulate membrane pro-
teins but differ greatly from environments based on bio-
logical membranes. Detergent micelles such as sodium
dodecyl sulfate and dodecylphosphorylcholine (DPC) are
able to bettermimicmembranes (6–9). Lipid bilayers or large
bicelles (q>2.5) are regarded as the best membrane-mimetic
model for the structural analysis of these peptides. However,
they are not convenient for solution NMR, although transfer
nuclear Overhauser effect (NOE) experiments have occa-
sionally been performed to deduce valuable structural infor-
mation (7,11). Solid-state NMR of aligned samples is well
suited for determining the in-plane or transmembrane orien-
tation of antimicrobial peptides. Therefore, a refined peptide
structure from lipid micelles should be more transportable toSubmitted January 31, 2011, and accepted for publication June 23, 2011.
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tion by solid-state NMR spectroscopy (12,13).
LPcin-I is a cationic amphipathic peptide with 23-amino
acid residues, and corresponds to the carboxy terminal 113–
135 region of component-3 of proteose peptone from bovine
milk. LPcin-I inhibits the growth of both Gram-negative and
Gram-positive bacteria, but has no hemolytic activity at
concentrations of <200 mM (14). In contrast to LPcin-I, it
has been reported that LPcin-II, which corresponds to the
119–135 region of PP3, has no antibacterial activity, which
is interesting because LPcin-I and LPcin-II have similar
charge ratios and identical hydrophobic/hydrophilic sectors
based on the helical wheel pattern (15–17). Furthermore,
both peptides show cationic properties and interact with
phospholipids. Nevertheless, only LPcin-I is incorporated
into planar lipidic bilayers, in which it forms voltage-depen-
dent channels (17).
To elucidate the structure-activity relationship of the
peptides, we examined the tertiary structures of LPcin-I
and LPcin-II in membrane-mimicking environments.
Uniformly 15N-labeled peptides were prepared as described
previously (18). Electrospray ionization mass spectrometry
(ESI-MS, Applied Biosystems, Carlsbad, CA) was used to
confirm the identity and purity of the recombinant LPcin-I
and LPcin-II peptides prepared for NMR experiments. To
examine the antimicrobial activities of the recombinant
peptides, their antimicrobial activity was screened against
five microorganisms using the agar hole diffusion method.
The interactions between these peptides and the membrane
were also studied by circular dichroism (CD, Jasco, Easton,
MD), solution, and solid-state NMR spectroscopy. The
tertiary structures of LPcin-I and LPcin II in the presence
of DPC micelles were determined by solution NMR spec-
troscopy. The structure and topology of LPcin-I anddoi: 10.1016/j.bpj.2011.06.067
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investigated by solid-state NMR spectroscopy. The struc-
tural differences between LPcin-I and LPcin-II peptides
were compared and demonstrated in each case.MATERIALS AND METHODS
Expression and purification
The coding sequence for the polypeptides corresponding to LPcin-I and
LPcin-II was synthesized and cloned into the pET31b(þ) vector (Novagen,
Darmstadt, Germany), as described previously (18). For the uniform 15N
enrichment of the peptides, cells were grown in minimal medium, which
included (15NH4)2SO4 (Sigma-Aldrich, St. Louis, MO) as the sole nitrogen
source. The fusion proteins were purified by Ni-nitrilotriacetic acid affinity
chromatography under denaturing conditions, and the target peptides were
cleaved from their ketosteroid isomerase fusion protein with CNBr. The
final purification of LPcin-I and LPcin-II was achieved by preparative
reversed-phase high performance liquid chromatography.Mass spectrometry
The mass spectrometry analysis of LPcin-I and LPcin-II was performed
with a Q-TOF instrument (QSTAR Elite, Applied Biosystems) with an
electrospray nano-ion source. The purified peptides were dissolved in 2%
acetonitrile/98% water.Antimicrobial activity test
The antimicrobial activity tests for the recombinant peptides, LPcin-I
and LPcin-II, against the microorganisms were carried out using Mueller-
Hinton agar (Difco) (BD, Sparks, MD). Five microorganisms belonging
to two Gram-positive (Listeria innocua MC2 KCTC (Daejon, Korea)
3658 and Staphylococcus aureus ATCC 6538) and three Gram-negative
(Pseudomonas aeruginosa ATCC27853, Salmonella ATCC (Manassas,
VA) 19430, Escherichia coli KCTC 1682) bacterial species were tested for
their susceptibility to the recombinant peptide based on the agar hole diffu-
sion test. The inoculumwas prepared from an overnight culture of bacteria in
5 mL of tryptic soy broth at 37C. The turbidity of the suspension was
adjusted with a spectrophotometer at 600 nm to obtain a final concentration
matching that of a 0.5 McFarland standard. 20 mL of Mueller-Hinton agar
was put in anØ90mmcell culture plate. The agar plateswere inoculatedwith
40 mL of bacterial suspension using a sterile spreader. The inoculated agar
plate was allowed to dry for 30 min at room temperature. The antimicrobial
peptides were dissolved in sterilizedwater at a concentration of 6mg/mL, and
30 mL of the solution was dropped onto the surface of the agar plate. After
prediffusion at room temperature for 1 h, the plates were incubated at
37C for 18 h. The susceptibility of the bacterial strains to the recombinant
antimicrobial peptides was determined by examining the size and clearance
of the inhibitory zone. All of themeasurements were done in three replicates.Circular dichroism
The CD experiments were carried out using a Jasco J715 spectropolarimeter
and 1 mm path-length quartz cuvettes. The spectra were recorded between
195 and 250 nmwith a data pitch of 0.2 nm, a bandwidth of 1 nm, a scanning
speed of 50 nm/min, and a response time of 0.25 s. 150 mM peptide samples
were prepared in water and in water containing 20–100 mMDPC at pH 4.0.
All of the CD spectra were collected at 25C. The data shown were aver-
aged from five individual spectra. The measurement of the buffer without
the peptide was subtracted to correct the baseline of the final spectra. The
CD signal J (mdeg) was converted to the mean residue molar ellipticity
[q], in degrees cm2 dmol1.Biophysical Journal 101(5) 1193–1201NMR sample preparation
The two kinds of samples used in the solution NMR experiments were
prepared in the same manner as in the CD experiments. The recombinant
peptides of the uniformly 15N-labeled LPcin-I and LPcin-II were dissolved
at a concentration of 1mM in 90%H2O and 10%D2O at pH 4.0. Themicelle
samples were then prepared by dissolving the uniformly 15N-labeled peptide
at a concentration of 1 mM in 150 mM DPC-d38 containing 90% H2O and
10% D2O at pH 4.0. The bicelle samples used in the solid-state NMR exper-
iments were prepared by dissolving 3 mg of the uniformly 15N-labeled
peptide in a long-chain and short-chain lipid mixture. The dried peptide
was mixed with 9.2 mg of 1,2-di-O-hexyl-sn-glycero-3-phosphocholine
(6-O-PC) (Avanti) in 100 mL of water with vortexing. The dissolved
protein/lipid mixture was added to 37.4 mg of 1,2-Di-Otetradecyl-sn-
glycero-3-phosphocholine (14-O-PC) (Avanti) and 9.5 mg of dimyristoyl-
phosphatidylglycerol (Avanti) in 100 mL of water to make a bicelle sample
that was 28% lipid (w/v) and had a q-value (long chain/short chain) of
3.4. The bicelles were formed by putting the sample through several
heating/cooling/vortexing cycles. The sample was transferred to a flat
bottomed NMR tube (4 mmØ  25 mm, Wilmad) and sealed with parafilm
and Teflon tape.Solution NMR spectroscopy
The solution NMR experiments were carried out at 308 K on a Varian
VNMRS 900 MHz spectrometer (Agilent Technologies, Santa Clara, CA)
equipped with a z-gradient cryogenic probe. Two-dimensional (2D) total
correlation spectroscopy (TOCSY), nuclear Overhauser enhancement spec-
troscopy (NOESY), and double-quantum filtered correlation spectroscopy
(DQF-COSY) were conducted to identify the spin systems and to assign
all of the resonances from LPcin-I and LPcin-II. The mixing times for
TOCSY were 30 ms and those for NOESY were 80 ms for both LPcins.
The solvent suppression for these spectra was accomplished by the presatu-
ration of the H2O resonance with continuous irradiation. All of the spectra
were acquired with time domains of 1024 (F2)  512 (F1) complex points
and with spectral widths of 11,261 Hz for both dimensions. By using 15N-
labeled peptides, 2D 1H-15N heteronuclear single quantum correlation
(HSQC) spectra, and three-dimensional (3D) 15N-edited NOESY-HSQC
spectra with a mixing time of 80 ms were also acquired to confirm the reso-
nance assignments and to generate the distance restraints. All of the spectra
were processed using NMRPipe/NMRDraw software (19) and analyzed by
NMRView software (20).Structural calculation
The NOE crosspeaks from the 2D NOESY spectra and 3D 15N-edited
NOESY-HSQC spectra of LPcin-I and LPcin-II were assigned by a semiau-
tomated method using the program ARIA 2.0 (21). The NOE-based
distance restraints were derived based on the peak volume. The backbone
dihedral angle restraints were obtained from the 3JHNCa coupling constants
measured in the DQF-COSY and HMQC-J spectra of each peptide. The
peptide structures were determined by using the programs, CNS 1.2 (22)
and ARIA 2.0 (21). Hydrogen bond restraints were incorporated into the
final calculation of the peptide structures based on the secondary structure
of each peptide. In the final ARIA run, 100 structures each for LPcin-I and
LPcin-II were calculated and the 20 lowest energy structures among them
were selected for the statistical analysis using PROCHECK-NMR 3.4 (23).Solid-state NMR spectroscopy
The solid-state NMR experiments were performed on a CMX Infinity
plus-700 spectrometer (Jeol, Tokyo, Japan)with a three channel high-power-
amplifier. AChemagnetics 4mmT3HXYCP/MASProbewas double-tuned
to the resonance frequencies of 1H (699.7 MHz) and 15N (70.9 MHz) in
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static 15N NMR spectra of LPcin-I and LPcin-II in the magnetically aligned
phospholipids bicelles were obtained at 35C using a Chemagnetics
variable-temperature stack and controller. The one-dimensional (1D)
15N chemical shift spectra were obtained using single-contact spin-lock
cross-polarization (24) with a contact time of 1 ms and recycle delay of
5 s. The data were acquired for 5 ms with a TPPM 1H decoupling power of
50 kHz (25). 2D separated local field spectra were obtained using a SAMMY
pulse sequence (26). The SAMMY spectra provide a measure of the 1H-15N
heteronuclear dipolar coupling in one dimension and the 15N chemical shift
in the other dimension.The chemical shift frequencies are referenced relative
to that of external solid, powdered 15N ammonium sulfate, which is defined
as 26.8 ppm.RESULTS AND DISCUSSION
ESI-MS spectrometry of LPcin-I and LPcin-II
Recombinant LPcin-I and LPcin-II peptides were prepared
as described previously (18). The sequences of these two
peptides are shown in Fig. 1, A and B, respectively. The
underlined residues are from native bovine lactophoricin
and six additional residues GGKKKK were added to
enhance the solubility for the isolation, purification, and
antibacterial activity test. The final residue Mhsl is homoser-
ine lactone resulting from CNBr cleavage, which was deter-
mined from the theoretical molecular weight of the
recombinant peptides compared with the experimental
molecular weight obtained from the mass spectrum. The
lyophilized peptides were dissolved in 2% acetonitrile and
used for ESI-MS for further identification. The measured
molecular masses of LPcin-I (Fig. 1 A) and LPcin-II
(Fig. 1 B) obtained by HPLC purification were 3391 andFIGURE 1 ESI-MS spectra of uniformly 15N-labeled LPcin-I (A) and
LPcin-II (B) obtained by HPLC purification. The measured molecular
masses of LPcin-I and LPcin-II were 3391 and 2719 Da, respectively, which
matches well with their theoretical molecular weights.2719 Da, respectively, which matches well with their theo-
retical molecular weights.Antimicrobial activity tests of recombinant
LPcin-I and LPcin-II
We examined the antimicrobial activities of the recombinant
peptides, LPcin-I and LPcin-II, against a representative set
of bacterial strains including two Gram-positive (Listeria,
S. aureus) and three Gram-negative (P. aeruginosa,
Salmonella, E. coli) strains. The antimicrobial activity was
screened using the agar hole diffusion test. The appearance
of clear zones in the agar overlay was considered to
represent strong inhibition, whereas a clearing but cloudy
zone was considered to represent weak inhibition and no
zone to no inhibition. LPcin-I peptide showed a strong inhi-
bition zone against four of the tested bacteria (Listeria,
P. aeruginosa, Salmonella, and E. coli) and a weak inhibi-
tion zone against one tested bacteria (S. aureus), as shown
in Fig. 2 A. On the other hand, LPcin-II peptide showed
a weak inhibition zone against only one of the tested
bacteria (Salmonella) and no inhibition against the other
tested bacteria, as shown in Fig. 2 B.CD measurements of LPcin-I and LPcin-II
We investigated the secondary structures of LPcin-I and
LPcin-II in aqueous and membrane-like environments by
analyzing their CD spectra. In Fig. 3, A and C, both peptides
have random structures in aqueous solution, but exhibit
conformational changes and form a-helical conformations
in 100 mMDPCmicelles, as is evident in the double minima
absorption observed at 208 and 222 nm. These helical
secondary structures are very stable and similar in 20, 40,
60, 80, and 100 mM DPC micelle environments (Fig. 3, B
and D).Solution NMR studies of LPcin-I and LPcin-II
The initial solution NMR studies of LPcin-I and LPcin-II
provided valuable information about their structure and
topology. To compare the structural differences betweenFIGURE 2 Results of the antimicrobial activity tests for the recombinant
LPcin-I (A) and LPcin-II (B) against five microorganisms belonging to two
Gram-positive (Listeria innocua MC2 KCTC 3658 and Staphylococcus
aureus ATCC 6538) and three Gram-negative (Pseudomonas aeruginosa
ATCC27853, Salmonella ATCC 19430, Escherichia coli KCTC 1682)
bacterial species.
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FIGURE 4 1H-15N HSQC spectra of uniformly 15N-labeled LPcin-I
(black) and LPcin-II (gray) in water solution (A) and in 150 mM DPC
micelles (B) are shown overlapped.
FIGURE 3 CD spectra of LPcin-I (A) and
LPcin-II (C) in water solution and in 100 mM
DPC micelles are shown on the left hand side.
The CD spectra of LPcin-I (B) and LPcin-II (D)
in 20, 40, 60, 80, and 100 mM DPC micelles are
shown on the right hand side.
1196 Park et al.the two peptides, their 1H-15N HSQC spectra were recorded
in aqueous and membrane-like environments. Each amide
site in the uniformly 15N-labeled peptides contributes
a single correlation resonance to the 2D 1H-15N HSQC
spectra in Fig. 4. Each resonance is characterized by 1H
and 15N chemical shift frequencies that reflect the local
environment of the site in the peptides. As expected, there
are fewer resonances in the spectrum obtained from
LPcin-II than that obtained from LPcin-I. In Fig. 4 A,
many of the resonances that are in the spectrum of LPcin-II
(gray) can be matched to those found in the spectrum of
LPcin-I (black). This suggests that the residues of LPcin-I
and LPcin-II have essentially identical local structures in
an aqueous environment. The backbone amide resonances
from both peptides in an aqueous environment are observed
with the narrow dispersion of the amide 1H chemical shifts
in the 1H-15N HSQC and 1H-1H NOESY spectra, and they
display no HN-HN NOE crosspeaks. This suggests that
they are not structured in an aqueous environment. These
results are consistent with the CD data in Fig. 3, A and C.
Fig. 4 B shows a comparison of the 1H-15N HSQC spectra
between LPcin-I (black) and LPcin-II (gray) in the
150 mM DPC micelles. The excellent dispersion of theBiophysical Journal 101(5) 1193–1201amide 1H signals between 7.5 and 9.0 ppm indicates that
the peptides are properly folded in a membrane-like envi-
ronment. There are significant differences in their chemical
NMR Structural Studies of LPcin-I and II 1197shifts compared to those observed in an aqueous environ-
ment. To obtain a better understanding of the structure-anti-
microbial activity relationship between the LPcin-I and
LPcin-II peptides, their 3D structures were determined by
solution NMR spectroscopy under micelle conditions, and
the structure and topology of the helical peptides were
also investigated by solid-state NMR spectroscopy under
aligned large bicelle conditions, as discussed below.Resonance assignments of LPcin-I and LPcin-II
Most of the 1H and 15N resonances of LPcin-I and LPcin-II
were unambiguously assigned in the analysis of the 2D
NOESY, TOCSY, DQF-COSY, 1H-15N HSQC, and 3D
15N-edited NOESY-HSQC spectra of the peptides. The
assigned resonances are summarized in Table 1 and theTABLE 1 Summary of the resonance assignments of LPcin-I and L
LPcin-I
HN N aH bH Others
1 Asn 3.04 gNH2 7.87, 7.03
2 Thr 8.81 115.28 4.47 4.47 gCH3 1.28
3 Val 8.94 124.15 3.67 2.22 gCH3:1.12, 0.98
4 Lys 8.35 119.23 3.92 1.90, 1.84 gCH2:1.57;
dCH2:1.73; εCH2:2.98
5 Glu 8.01 117.99 4.09 2.14 gCH2:2.42
6 Thr 8.24 119.21 4.00 4.38 gCH3:1.25
7 Ile 8.41 121.53 3.65 2.03 gCH2:1.81 1.19;
gCH3:0.96; dCH3:0.86
1
8 Lys 7.85 119.63 3.92 1.96 gCH2:1.61, 1.43;
dCH2:1.71; εCH2:2.96
2
9 Tyr 8.01 120.57 4.34 3.29, 3.23 2,6H:7.08; 3,5H:6.77 3
10 Leu 8.61 120.03 3.88 2.02, 1.39 gCH:2.09; dCH3:0.93 4
11 Lys 8.69 118.19 3.90 2.00, 1.94 gCH2:1.35;
dCH2:1.67; εCH2:2.88
5
12 Ser 7.79 115.26 4.01 4.28 6
13 Leu 8.05 123.83 4.05 1.59, 1.45 gCH:1.40;
dCH3:0.78, 0.74
7
14 Phe 8.43 117.32 4.22 3.13 2,6H:7.20;
3,5H:7.11; 4H:7.03
8
15 Ser 8.36 114.23 4.19 4.07, 4.03 9
16 His 8.13 118.86 4.58 3.37 2H:7.26 1
17 Ala 8.34 121.65 3.95 1.42 1
18 Phe 8.32 115.87 4.18 3.25, 3.03 2,6H:7.23; 3,5H:7.27 1
19 Glu 7.77 117.42 4.03 2.21, 2.19 gCH2:2.49 1
20 Val 7.85 118.86 3.77 2.16 gCH3:0.90 1
21 Val 7.86 119.10 3.80 2.11 gCH3:1.01, 0.92 1
22 Lys 8.05 119.80 4.08 1.70, 1.64 gCH2:1.29; dCH2:1.55 1
23 Thr 7.87 111.15 4.30 4.34 gCH3:1.25 1
24 Gly 8.17 110.73 3.98 1
25 Gly 8.30 108.11 3.94 1
26 Lys 8.06 120.38 4.29 1.82, 1.75 gCH2:1.45 2
27 Lys 2
28 Lys 2
29 Lys 2
30 Met 8.62 117.68 4.64 21H-15N HSQC spectra of LPcin-I and LPcin-II are shown
in Fig. 5. The C-terminal regions of LPcin-I (Ser-15-Met-
30) and LPcin-II (Ser-9-Met-24) showed significant spectral
overlap in the 1H-15N HSQC spectra, whereas the
N-terminal 8 amino acids of LPcin-II revealed a significantly
different chemical shift compared to the corresponding
region of LPcin-I. Not only the backbone 1H and 15N reso-
nances, but also the whole 1H resonances, showed the same
spectral tendency. Because LPcin-II lacks 6 amino acids
compared to LPcin-I, the chemical shifts differed only in
the N-terminal part of the peptides. However, the overall
structures of LPcin-I and LPcin-II resembled each other
very well and will be discussed later. The resonances of
the solubilization-tags (GGKKKK) from both peptides
could not be assigned, because the signals from these resi-
dues were not separated in the 2D TOCSY and NOESYPcin-II
LPcin-II
HN N aH bH Others
Ile 3.85 1.96 gCH2:1.63, 1.28;
gCH3:1.01; dCH3:0.95
Lys 4.16 1.63, 1.53 gCH2:1.31, 1.15;
dCH2:1.58; εCH2:2.90
Tyr 8.24 117.08 4.41 3.18, 3.04 2,6H:7.08; 3,5H:6.83
Leu 8.21 119.67 4.02 1.71, 1.59 gCH:1.70;
dCH3:0.98, 0.92
Lys 8.29 117.94 3.98 1.91 gCH2:1.52, 1.45;
dCH2:1.76, 1.74;
εCH2:2.96
Ser 8.10 114.67 4.33 3.98, 3.95
Leu 8.03 122.85 4.10 1.71, 1.60 gCH:1.59;
dCH3:0.88, 0.80
Phe 8.23 116.75 4.27 3.18, 3.15 2,6H:7.24;
3,5H:7.17; 4H:7.08
Ser 8.40 114.20 4.21 4.04, 4.01
0 His 8.17 118.65 4.57 3.32 2H:7.26
1 Ala 8.34 121.64 3.97 1.43
2 Phe 8.32 115.88 4.20 3.24, 3.04 2,6H:7.24;
3,5H:7.08, 4H:7.28
3 Glu 7.78 117.31 4.03 2.21, 2.17 gCH2:2.46, 2.44
4 Val 7.82 118.40 3.80 2.19 gCH3:0.97, 0.92
5 Val 7.79 118.36 3.81 2.13 gCH3:1.01, 0.92
6 Lys 8.01 119.73 4.09 1.70, 1.94 gCH2:1.29; dCH2:1.56
7 Thr 7.88 111.44 4.33 4.33 gCH3:1.25
8 Gly 8.22 110.76 3.97
9 Gly 8.32 108.05 3.94
0 Lys 8.04 120.30
1 Lys
2 Lys
3 Lys
4 Met 8.61 117.61
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FIGURE 5 1H-15N HSQC spectra of LPcin-I (A) and LPcin-II (B). On top
of each spectrum, the primary sequences of LPcin-I and LPcin-II were indi-
cated by the one-letter codes of the amino acids. The C-terminal sequence
of GGKKKK was added to express and solubilize each peptide and the last
methionine was introduced for the cleavage by CNBr. The assignments of
the backbone 1H and 15N resonances were also indicated on the HSQC
spectra of LPcin-I and LPcin-II. The asterisked crosspeaks in the lower
center of each spectrum could not be assigned, but were attributed to the
C-terminal lysine residues, because of the slow conformational exchange
of these residues (see text).
TABLE 2 Structural statistics for the final 20 structures of
LPcin-I and LPcin-II
LPcin-I LPcin-II
Number of experimental restraints
NOE distance restraints 336 234
Hydrogen bond restraints 32 22
Torsion angle restraints 42 26
Number of violations
NOE > 0.3 (A˚) 0 0
Dihedral angle > 0.5 () 0 0
Energies (kcal/mol)
Etotal 1013.705 48.72 774.975 40.67
Ebond 0.675 0.02 0.455 0.07
Eangle 12.425 0.37 9.925 0.27
Eimproper 0.775 0.12 0.525 0.05
Edihed 140.245 2.08 109.395 1.57
Evdw 237.965 3.46 186.135 3.60
Eelec 929.835 49.48 679.115 41.36
ENOE 2.915 1.53 0.985 0.27
Root mean-square deviations (RMSD) from experimental restraints
NOE (A˚) 0.0125 0.003 0.095 0.001
Torsion angle () 0.0255 0.038 0.1315 0.092
RMSD from the idealized geometry
Bonds (A˚) 0.0015 0.000 0.0015 0.000
Bond angles () 0.2945 0.004 0.2915 0.004
Improper angles () 0.1425 0.011 0.1275 0.007
Ramachandran plot (%)*
Most favored 88.7 81.0
Additionally allowed 8.5 13.8
Generously allowed 1.5 4.0
Disallowedy 1.3 1.2
RMSD of well-ordered region (A˚)z
Backbone 0.44 0.30
Heavy atoms 1.28 1.16
*As determined y PROCHECK-NMR.
y
1198 Park et al.spectra, except for two glycines. At least 3 out of 4 lysines in
the tag presented multiple 1H-15N correlation peaks in the
lower center of the HSQC spectra, which suggests that these
regions are very dynamic and under a slow exchange regime
on the 900 MHz frequency timescale.Disallowed regions were from the seven lysine residues in the disordered
region in LPcin-I and from five lysines in LPcin-II.
zRMSD was calculated by using the software MOLMOL (27) for the well-
ordered residues of LPcin-I (Thr-2–Thr-23) and LPcin-II (Tyr-3–Thr-17).Overall structures of LPcin-I and LPcin-II
The 3D structures of LPcin-I and LPcin-II were determined
based on the NOE-derived distance restraints, dihedral
angle restraints, and hydrogen bond restraints. The numbers
of experimental restraints and statistics for the calculated
LPcin-I and LPcin-II are summarized in Table 2. Each
peptide consists of a single a-helix spanning from Thr-2
to Thr-23 for LPcin-I and from Tyr-3 to Thr-17 for LPcin-II
(Fig. 6, A and B). The C-terminal additional residues are
disordered in each peptide. The backbone root mean-square
deviations of LPcin-I and LPcin-II were 0.44 and 0.30 A˚,
respectively. The Ramachandran plots showed disallowed
spaces of 1.3 and 1.2% in LPcin-I and LPcin-II, respec-
tively, however, these disallowances occurred only on the
C-terminal lysine residues. The a-helix of LPcin-I was
slightly curved, whereas that of LPcin-II was straight.Distribution of hydrophobic residues in LPcin
peptides
Because each peptide was dissolved in DPC micelles, the
binding interface of the peptides to the micelles was of greatBiophysical Journal 101(5) 1193–1201interest to investigate the interaction of the LPcins with the
cell membrane. The 3D structures determined in this work
provided clues to the interaction and orientation of the
peptides with respect to the membrane using solid-state
NMR spectroscopy. The hydrophilic residues of LPcin-I
were distributed on one side of a single a-helix and the
hydrophobic and hydrophilic residues were situated on
the other side of the helix. Fig. 7 A shows the distribution
of the hydrophobic, polar, and charged residues on the
surface of LPcin-I. One more interesting point was the slight
curvature of the helix of LPcin-I. The concave surface of
LPcin-I consisted of the hydrophobic residues, although
the convex surface of the peptide consisted of the polar
and charged residues. This curvature might be induced on
the surface of the micelle sphere where the binding between
LPcin-I and micelles occurs. On the other hand, the struc-
ture of LPcin-II was straight, because the length of the
peptide is insufficient. The pattern of side-chain distribution
was quite similar to that shown in LPcin-I and is indicated in
Fig. 7 B.
FIGURE 6 Overall structures of LPcin-I and LPcin-II. The ensembles of
the 20 lowest energy structures of LPcin-I (A) and LPcin-II (B). Each
peptide consists of a single a-helix spanning from Thr-2 to Thr-23 for
LPcin-I and from Tyr-3 to Thr-17 for LPcin-II, and the C-terminal addi-
tional residues are disordered. LPcin-I was slightly curved, whereas
LPcin-II was straight.
NMR Structural Studies of LPcin-I and II 1199Solid-state NMR studies of LPcin-I and LPcin-II
The initial experimental results consist of the 1D and 2D
solid-state NMR spectra of the uniformly 15N-labeled
samples of LPcin-I and LPcin-II containing a single amphi-
pathic in-plane helix in magnetically aligned unflipped
bicelles that have their normals perpendicular to the direc-
tion of the applied magnetic field. Solid-state NMR spectra
are strongly affected by the molecular motion and orienta-FIGURE 7 Distribution of side chains in LPcin-I (A), LPcin-II (B), over-
laid structures (C). For each peptide, the hydrophobic residues are situated
on one side of the helix and the charged and polar residues on the other side.
The concave surface of the slightly curved LPcin-I consisted of the hydro-
phobic residues, which might be the micelle-binding site. The hydrophobic,
positively and negatively charged, and polar amino acids were indicated
in gray, blue, red, and orange, respectively. Each residue was labeled
with one-letter amino acid codes and the sequence.tion. In the spectrum of an unoriented sample with multiple
labeled sites without additional sample manipulations, no
resolution among the resonances is feasible. This is because
most of the backbone sites are structured and immobile
on the timescale of the 15N chemical shift interaction
(10 kHz) and contribute to the characteristic amide powder
pattern between ~220 and 60 ppm (28). In contrast, sample
orientation gives well-resolved spectra that retain the orien-
tational information used for structure determination.
Each 15N-labeled site on the aligned samples contributes a
single-line resonance, whose frequency is determined by
the orientation of the peptide plane containing the amide
group relative to the direction of the applied magnetic field.
There is no evidence of residual powder pattern line shapes
in the 1D 15N NMR spectra of LPcin-I (Fig. 8 A) and LPcin-
II (see Fig. 8 C), suggesting that both peptides are well
aligned with the phospholipids in the bicelle samples.
Many of the resonances overlap in the spectra of the
uniformly 15N-labeled samples, because the amide sites in
an a-helix have similar orientations. The 15N resonance
linewidth of LPcin-I is ~10 ppm broader than that of
LPcin-II, as shown in Fig. 8, A and C. This broadening is
to be expected, based on the additional six N-terminal resi-
dues of LPcin-I and the presence of a kinked or curved
helical structure in the membrane environment.
2D SAMMY spectra contain much more structural infor-
mation than 1D spectra. Each resonance in the SAMMY
spectra can be characterized by two orientationally depen-
dent frequencies, 15N chemical shift and 1H-15N heteronu-
clear dipolar coupling. The observed 15N chemical shift is
a function of the angle between the 1H-15N heteronuclear
bond axis and the magnetic field. Orientational information
can also be obtained from the N-H dipolar interaction (29).
Furthermore, high-resolution SAMMY spectra of uniformly
15N-labeled helical peptides have resonances in the form of
characteristic PISA wheel patterns that provide a direct
measurement of the helix tilt and rotation (30–32). Fig. 8,
B and D, show the initial experimental SAMMY spectra
of the uniformly 15N-labeled samples of LPcin-I and
LPcin-II in the unflipped bicelles, respectively. Signifi-
cantly, there are signal intensities that are discernible at the
isotropic frequency (~120 ppm), which indicates that nearly
all of the residues are structured and immobilized along with
the rest of the protein in the phospholipid bilayers. The
partially resolved resonance intensity between 70 and 120
ppm is consistent with transmembrane helices that are
well aligned in unflipped bicelles (33). As indicated in
Fig. 8, B and D, most of the residues in the LPcin-I and
LPcin-II peptides are integrated into the membrane, respec-
tively. However, the observed resonances in the SAMMY
spectrum of LPcin-I (Fig. 8 B) are distributed over a wide
range of 76–134 ppm in the 15N chemical shift dimension.
On the other hand, the resonances from LPcin-II are present
in a narrow range of 94–121 ppm. These results suggest that
the structure of LPcin-II is a nearly straight helix, whereasBiophysical Journal 101(5) 1193–1201
FIGURE 8 1D solid-state NMR spectra of
uniformly 15N-labeled LPcin-I (A) and LPcin-II
(C) in magnetically aligned bicelles and 2D
SAMMY spectra of uniformly 15N-labeled
LPcin-I (B) and LPcin-II (D) samples. The spectra
were obtained at 700 MHz on 160 mL samples
with 3 mg of 15N-labeled peptides. The mix time
was 1 ms; the acquisition time was 5 ms during
which TPPM 1H decoupling (25) was applied,
and the recycle delay was 5 s. The data were pro-
cessed with 100 Hz of exponential line broadening
applied in t2 followed by Fourier transformation.
1200 Park et al.that of LPcin-I has some deviation from ideality, such as
kinks or curvatures.CONCLUSION
Lactophorin is a minor phophoglycoprotein found in bovine
milk and its homologous proteins are also found in milk of
other species such as camel, llama, ewe, and goat, but not in
human milk (14). LPcin-I is a cationic amphipathic peptide
with 23-amino acid residues, and corresponds to the carboxy
terminal 113–135 region of component-3 of proteose
peptone and inhibits the growth of both Gram-negative
and Gram-positive bacteria. In contrast to LPcin-I, it has
been reported that LPcin-II, which corresponds to the
119–135 region of PP3, has no antibacterial activity, which
is interesting because LPcin-I and LPcin-II have similar
charge ratios and identical hydrophobic/hydrophilic sectors
and show cationic properties and interact with phospho-
lipids. Nevertheless, only LPcin-I is incorporated into
planar lipidic bilayers, in which it forms voltage-dependent
channels (17). We examined the tertiary structures of
LPcin-I and LPcin-II in membrane-mimicking environ-
ments to elucidate the structure-activity relationship of these
peptides.
Based on the antibacterial activity test, recombinant
LPcin-I showed much stronger antimicrobial activity than
recombinant LPcin-II in the agar hole diffusion test against
five microorganisms. The high-resolution solution and
solid-state NMR spectra demonstrate that the polypeptides
are well folded in micelle and bilayer membrane environ-
ments. The 3D solution structure of LPcin-I determined
under DPC micelle conditions was a slightly curved a-helix,
whereas that of LPcin-II was a straight a-helix. And the
solid-state NMR studies indicate that most of the residues
in both the LPcin-I and LPcin-II peptides are integratedBiophysical Journal 101(5) 1193–1201into the membrane. However, the larger chemical shift
dispersion of LPcin-I in 2D SAMMY spectra than that of
LPcin-II suggests that the structure of LPcin-I exhibits
some deviation from ideal straight a-helix, such as kinks
or curvatures in the membrane environments. This structural
specificity of curved a-helix of LPcin-I help to make a hole
in the bacterial membrane than straight a-helix of LPcin-II.
Therefore, the difference in the antimicrobial activities
between LPcin-I and LPcin-II peptides might result from
these different structural characteristics. The solid-state
NMR spectra in Fig. 8 are an early result and could be
improved by further optimizing the sample conditions.
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